GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sumitomo Pharma Co Ltd (TSE:4506) » Definitions » Cyclically Adjusted PS Ratio

Sumitomo Pharma Co (TSE:4506) Cyclically Adjusted PS Ratio : 0.25 (As of May. 21, 2024)


View and export this data going back to 1949. Start your Free Trial

What is Sumitomo Pharma Co Cyclically Adjusted PS Ratio?

As of today (2024-05-21), Sumitomo Pharma Co's current share price is 円309.00. Sumitomo Pharma Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was 円1,222.33. Sumitomo Pharma Co's Cyclically Adjusted PS Ratio for today is 0.25.

The historical rank and industry rank for Sumitomo Pharma Co's Cyclically Adjusted PS Ratio or its related term are showing as below:

TSE:4506' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 0.27   Med: 1.49   Max: 3.84
Current: 0.27

During the past years, Sumitomo Pharma Co's highest Cyclically Adjusted PS Ratio was 3.84. The lowest was 0.27. And the median was 1.49.

TSE:4506's Cyclically Adjusted PS Ratio is ranked better than
91.8% of 744 companies
in the Drug Manufacturers industry
Industry Median: 2.135 vs TSE:4506: 0.27

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Sumitomo Pharma Co's adjusted revenue per share data for the three months ended in Mar. 2024 was 円200.179. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is 円1,222.33 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Sumitomo Pharma Co Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Sumitomo Pharma Co's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sumitomo Pharma Co Cyclically Adjusted PS Ratio Chart

Sumitomo Pharma Co Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.33 1.79 1.06 0.66 0.33

Sumitomo Pharma Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.66 0.52 0.44 0.38 0.33

Competitive Comparison of Sumitomo Pharma Co's Cyclically Adjusted PS Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Sumitomo Pharma Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sumitomo Pharma Co's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sumitomo Pharma Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Sumitomo Pharma Co's Cyclically Adjusted PS Ratio falls into.



Sumitomo Pharma Co Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Sumitomo Pharma Co's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=309.00/1222.33
=0.25

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sumitomo Pharma Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Sumitomo Pharma Co's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=200.179/107.2000*107.2000
=200.179

Current CPI (Mar. 2024) = 107.2000.

Sumitomo Pharma Co Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 225.891 98.000 247.097
201409 222.860 98.500 242.544
201412 253.831 97.900 277.944
201503 232.137 97.900 254.189
201506 246.960 98.400 269.046
201509 253.718 98.500 276.128
201512 265.807 98.100 290.464
201603 248.370 97.900 271.964
201606 260.493 98.100 284.657
201609 238.114 98.000 260.468
201612 270.354 98.400 294.532
201703 258.867 98.100 282.880
201706 292.392 98.500 318.217
201709 289.918 98.800 314.567
201712 311.615 99.400 336.068
201803 281.106 99.200 303.776
201806 291.749 99.200 315.277
201809 277.485 99.900 297.762
201812 303.844 99.700 326.701
201903 282.902 99.700 304.183
201906 295.709 99.800 317.635
201909 284.723 100.100 304.918
201912 318.187 100.500 339.399
202003 316.427 100.300 338.195
202006 336.921 99.900 361.541
202009 321.276 99.900 344.753
202012 335.429 99.300 362.115
202103 305.039 99.900 327.329
202106 330.225 99.500 355.780
202109 409.104 100.100 438.121
202112 348.212 100.100 372.910
202203 322.087 101.100 341.521
202206 402.414 101.800 423.760
202209 401.249 103.100 417.206
202212 354.842 104.100 365.409
202303 239.821 104.400 246.253
202306 190.505 105.200 194.127
202309 193.702 106.200 195.526
202312 207.369 106.800 208.146
202403 200.179 107.200 200.179

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Sumitomo Pharma Co  (TSE:4506) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Sumitomo Pharma Co Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Sumitomo Pharma Co's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Sumitomo Pharma Co (TSE:4506) Business Description

Traded in Other Exchanges
Address
6-8, Doshomachi 2-chome, Chuo-ku, Osaka, JPN, 541-0045
Sumitomo Pharma Co Ltd is a specialty and generic drug manufacturing company. Sumitomo's vast majority of sales are generated in North America, followed by Japan. The company's core business is its pharmaceutical products business. The pharmaceutical business maintains a focus on a variety of areas, including cardiovascular/diabetes, psychiatry & neurology, and specialty areas. Sumitomo considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Sumitomo Pharma Co (TSE:4506) Headlines

No Headlines